Extract

The purpose of this study is to examine the safety of Ipilimumab and patterns of use in the treatment of unresectable or metastatic melanoma in the post-approval setting.

Inclusion criteria

• Advanced Cutaneous Melanoma

Country

• Argentina
• Australia
• Austria
• Belgium
• Canada
• France
• Germany
• Greece
• Ireland
• Israel
• Poland
• Spain
• Switzerland
• United Kingdom
• United States

Links

• nct
• ictrp